Dr. Luis Ostrosky-Zeichner
Dr. Ostrosky-Zeichner has consulted for the FDA and the CDC and has published over 170 peer-reviewed articles. He actively pursues translational and clinical research in medical mycology and hospital epidemiology. His areas of expertise include antifungal susceptibility testing, sero-diagnostics, PK/PD of antifungals, in vivo models of human mycoses, immunology, and clinical trials in prophylaxis and treatment of fungal infections, transplant infectious diseases, as well as hospital epidemiology, antimicrobial stewardship, and infection control. He has been coordinating the COVID-19 response at UTHealth and Memorial Hermann TMC since this outbreak began in early 2020.